Transcatheter Aortic Valve Implantation in the Presence of Aortic Coarctation: Current Evidence and Practical Approaches
BACKGROUND: Transcatheter aortic valve implantation (TAVI) has become an established treatment for severe aortic stenosis across a wide spectrum of surgical risk. As TAVI is increasingly used in younger patients and in those with congenital valve disease, the coexistence of aortic stenosis and untreated coarctation of the aorta (CoA) is being encountered more frequently. However, evidence guiding the procedural strategy in this complex anatomical setting remains limited. AIMS: To systematically review the published literature on TAVI in adult patients with untreated or residual coarctation of the aorta, focusing on patient characteristics, procedural strategies, vascular access selection, management of coexisting CoA, and clinical outcomes. METHODS: A systematic literature search was performed in PubMed, Wiley Online Library, ScienceDirect, and the Cochrane Library to identify published reports describing TAVI in adult patients with angiographically confirmed native or residual severe CoA. Case reports and case series published between January 2013 and September 2025 were included. Studies involving repaired CoA without restenosis or surgical aortic valve replacement were excluded. Clinical characteristics, access routes, procedural strategies, and outcomes were analyzed. RESULTS: Nine patients from published reports met the inclusion criteria. Hemodynamically significant CoA was present in five patients (55.6%). Bicuspid aortic valve anatomy was reported in six cases. Transcatheter access routes included transcarotid (44.4%), transfemoral (33.3%), transsubclavian (11.1%), and transaxillary (11.1%) approaches. A staged strategy with initial CoA stenting followed by TAVI was performed in two patients (22.2%), whereas seven patients (77.8%) underwent single-procedure management, including concomitant treatment of both lesions in two cases. Procedural success was achieved in all cases, although technical challenges related to valve delivery and stent expansion were occasionally encountered. CONCLUSIONS: TAVI in patients with untreated or residual CoA is feasible and can be performed with high procedural success when individualized strategies are applied. Access selection and the timing of CoA intervention should be guided by anatomical characteristics and hemodynamic severity. Given the limited evidence base, careful preprocedural planning and a multidisciplinary approach are essential to optimize outcomes in this complex patient population.
Authors
- Vilhelmas Bajoras (ORCID: https://orcid.org/0000-0002-0917-1442)
- Sigitas Čėsna (ORCID: https://orcid.org/0000-0001-7254-4099)
- Ričardas Kundelis (ORCID: https://orcid.org/0000-0001-9588-0474)
- Artiomas Širvys (ORCID: https://orcid.org/0000-0002-8158-2908)
- Giedrius Davidavičius (ORCID: https://orcid.org/0000-0003-4025-2221)
- Liudas Usoris
- Gintarė Petraitytė
Institutions
- Vilnius University (LT)
- Vilnius University Hospital Santariskiu Klinikos (LT)
Publication Details
- Journal
- Catheterization and Cardiovascular Interventions
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1002/ccd.70982
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00